Fabry-betegség: vizsgálatok itt: Németország
7 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 2026. november 11.. Ask the study team whether a trial fits you.
- 3. fázisTaking peopleA Study to Learn How Well Lucerastat Works and How Safe it is in Untreated Adult Male Participants With Fabry Disease
- Where
- Berlin, Wuerzburg
- Életkor
- 18 év to 60 év
- People
- 16 worldwide
- Run by
- Idorsia Pharmaceuticals Ltd.
See details and how to joinNCT07778667 · EU 2026-525207-27-00 - 3. fázisTaking peopleA Study of Migalastat in Pediatric Subjects (2 to <12 Yrs) With Fabry Disease and Amenable GLA Variants
- Where
- Münster
- Életkor
- 2 év to 11 év
- People
- 8 worldwide
- Run by
- Amicus Therapeutics
See details and how to joinNCT06904261 - No phaseTaking peopleFabry Disease Registry & Pregnancy Sub-registry
- Where
- Berlin, Giessen, Münster, Würzburg
- People
- 9000 worldwide
- Run by
- Genzyme, a Sanofi Company
See details and how to joinNCT00196742 - 3. fázisNot yet taking people in NémetországAn Open-label Study of the Safety, Pharmacokinetics, Pharmacodynamics, and Efficacy of 12-month Treatment with Migalastat in Pediatric Subjects (aged 2 to < 12 years) with Fabry Disease and Amenable GLA Variants
- Where
- Muenster
- Életkor
- Up to 17 év
- People
- 3 worldwide
- Run by
- Amicus Therapeutics Inc.
See details and how to join2025-521244-38-00 · EU 2025-521244-38-00 - No phaseTaking peopleMaternal and Postnatal Outcomes Study (MOS): A Global Observational Registry Assessing the Safety of Elfabrio® in Women With Fabry Disease and Their Infants During Pregnancy and Breastfeeding
- Where
- Berlin
- People
- 10 worldwide
- Run by
- Chiesi Farmaceutici S.p.A.
See details and how to joinNCT06941025 - No phaseTaking peopleCharacterizing the Retinal Microvasculature in Patients with Fabry Disease: a Prospective Observational Study
- Where
- München
- Életkor
- 18 év and over
- People
- 63
- Run by
- Technical University of Munich
See details and how to joinNCT06758648 - No phaseTaking peopleEvaluation of HEArt invoLvement in Patients With FABRY Disease
- Where
- Würzburg
- Életkor
- 18 év and over
- People
- 650
- Run by
- Wuerzburg University Hospital
See details and how to joinNCT03362164